Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3980729 | 0.91 | KDM4E (0.48) | KDM4EALDH1A1GAALMNARAB9A | |
| SCHEMBL4951146 | 0.91 | BCHE (0.54) | KDM4EALDH1A1GAALMNARAB9A | |
| SCHEMBL4951131 | 0.91 | BCHE (0.54) | KDM4EALDH1A1GAALMNARAB9A | |
| SCHEMBL4300080 | 0.91 | KDM4E (0.47) | KDM4EALDH1A1GAALMNARAB9A | |
| SCHEMBL3985981 | 0.90 | KDM4E (0.45) | KDM4EALDH1A1GAALMNARAB9A | |
| SCHEMBL4086901 | 0.90 | ALOX15 (0.56) | KDM4EALDH1A1GAALMNARAB9A | |
| SCHEMBL3978205 | 0.83 | SLC7A5 (0.44) | NR1H3MEN1KMT2ASLC7A5 | |
| SCHEMBL3978329 | 0.83 | BCHE (0.44) | KDM4ETDP1NR1H3MEN1KMT2A | |
| SCHEMBL3978325 | 0.83 | BCHE (0.44) | KDM4ETDP1NR1H3MEN1KMT2A | |
| SCHEMBL3978202 | 0.83 | SLC7A5 (0.44) | NR1H3MEN1KMT2ASLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8993628-B2 | Synthetic ligands selective for LXRβ over LXRα, identification and methods of use thereof | CITY OF HOPE (US) | 2015-03-31 | — | — | US | disclosed |
| US-20090030082-A1 | SYNTHETIC LIGANDS SELECTIVE FOR LXRbeta OVER LXRalpha, IDENTIFICATION AND METHODS OF USE THEREOF | CITY OF HOPE | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030082-A1 | SYNTHETIC LIGANDS SELECTIVE FOR LXRbeta OVER LXRalpha, IDENTIFICATION AND METHODS OF USE THEREOF | NR1H2, NR1H3, NR1H4 | KDM4E 4708/4885ALDH1A1 3749/4885GAA 481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.